148 related articles for article (PubMed ID: 24588115)
1. Melanoma prognosis in Europe: far from equal.
Forsea AM; Del Marmol V; Stratigos A; Geller AC
Br J Dermatol; 2014 Jul; 171(1):179-82. PubMed ID: 24588115
[TBL] [Abstract][Full Text] [Related]
2. Melanoma incidence and mortality in Europe: new estimates, persistent disparities.
Forsea AM; Del Marmol V; de Vries E; Bailey EE; Geller AC
Br J Dermatol; 2012 Nov; 167(5):1124-30. PubMed ID: 22759278
[TBL] [Abstract][Full Text] [Related]
3. Melanoma prognosis in the United States: Identifying barriers for improved care.
Hopkins ZH; Moreno C; Carlisle R; Secrest AM
J Am Acad Dermatol; 2019 May; 80(5):1256-1262. PubMed ID: 30659870
[TBL] [Abstract][Full Text] [Related]
4. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe.
de Vries E; Boniol M; Doré JF; Coebergh JW;
Eur J Cancer; 2004 May; 40(7):1045-52. PubMed ID: 15093581
[TBL] [Abstract][Full Text] [Related]
5. More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
Kandolf Sekulovic L; Peris K; Hauschild A; Stratigos A; Grob JJ; Nathan P; Dummer R; Forsea AM; Hoeller C; Gogas H; Demidov L; Lebbe C; Blank C; Olah J; Bastholt L; Herceg D; Neyns B; Vieira R; Hansson J; Rutkowski P; Krajsova I; Bylaite-Bucinskiene M; Zalaudek I; Maric-Brozic J; Babovic N; Banjin M; Putnik K; Weinlich G; Todorovic V; Kirov K; Ocvirk J; Zhukavets A; Kukushkina M; De La Cruz Merino L; Ymeri A; Risteski M; Garbe C
Eur J Cancer; 2017 Apr; 75():313-322. PubMed ID: 28264791
[TBL] [Abstract][Full Text] [Related]
6. Favorable liver cancer mortality-to-incidence ratios of countries with high health expenditure.
Wang CC; Tsai MC; Peng CM; Lee HL; Chen HY; Yang TW; Sung WW; Lin CC
Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1397-1401. PubMed ID: 29023320
[TBL] [Abstract][Full Text] [Related]
7. Socio-economic factors and health care system characteristics related to cancer survival in the elderly. A population-based analysis in 16 European countries (ELDCARE project).
Quaglia A; Vercelli M; Lillini R; Mugno E; Coebergh JW; Quinn M; Martinez-Garcia C; Capocaccia R; Micheli A;
Crit Rev Oncol Hematol; 2005 May; 54(2):117-28. PubMed ID: 15843094
[TBL] [Abstract][Full Text] [Related]
8. Global trends in testicular cancer incidence and mortality.
Rosen A; Jayram G; Drazer M; Eggener SE
Eur Urol; 2011 Aug; 60(2):374-9. PubMed ID: 21612857
[TBL] [Abstract][Full Text] [Related]
9. International variations in bladder cancer incidence and mortality.
Chavan S; Bray F; Lortet-Tieulent J; Goodman M; Jemal A
Eur Urol; 2014 Jul; 66(1):59-73. PubMed ID: 24451595
[TBL] [Abstract][Full Text] [Related]
10. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.
de Vries E; Bray FI; Coebergh JW; Parkin DM
Int J Cancer; 2003 Oct; 107(1):119-26. PubMed ID: 12925966
[TBL] [Abstract][Full Text] [Related]
11. Cost-of-illness of melanoma in Europe - a modelling approach.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():34-45. PubMed ID: 30811699
[TBL] [Abstract][Full Text] [Related]
12. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous melanoma.
Armstrong BK; Kricker A
Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
[TBL] [Abstract][Full Text] [Related]
14. Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries.
Lee HL; Peng CM; Huang CY; Wu SY; Tsai MC; Wang CC; Chen SL; Lin CC; Huang CN; Sung WW
BMJ Open; 2018 Jul; 8(7):e020618. PubMed ID: 29982202
[TBL] [Abstract][Full Text] [Related]
15. Improving Quality Indicator of Melanoma Management - Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study.
Várnai M; Kiss Z; Gyulai R; Oláh J; Holló P; Emri G; Csejtei A; Kenessey I; Benedek A; Polányi Z; Nagy-Erdei Z; Dániel A; Knollmajer K; Rokszin G; Fábián I; Barcza Z; Polgár C; Nagy B; Liszkay G; Vokó Z
Front Oncol; 2021; 11():745550. PubMed ID: 34745967
[TBL] [Abstract][Full Text] [Related]
16. Survival in patients with uveal melanoma in Europe.
Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
Arch Ophthalmol; 2008 Oct; 126(10):1413-8. PubMed ID: 18852420
[TBL] [Abstract][Full Text] [Related]
17. Incidence of uveal melanoma in Europe.
Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
Ophthalmology; 2007 Dec; 114(12):2309-15. PubMed ID: 17498805
[TBL] [Abstract][Full Text] [Related]
18. Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe.
Vrdoljak E; Bodoky G; Jassem J; Popescu R; Pirker R; Čufer T; Bešlija S; Eniu A; Todorović V; Kopečková K; Kurteva G; Tomašević Z; Sallaku A; Smichkoska S; Bajić Ž; Sikic B
Oncologist; 2019 Jan; 24(1):e30-e37. PubMed ID: 30181313
[TBL] [Abstract][Full Text] [Related]
19. Priorities and challenges for skin cancer prevention in Europe: an expert survey.
Forsea AM; Del Marmol V; Geller AC
Melanoma Res; 2013 Aug; 23(4):298-306. PubMed ID: 23777873
[TBL] [Abstract][Full Text] [Related]
20. Health disparities are associated with gastric cancer mortality-to-incidence ratios in 57 countries.
Tsai MC; Wang CC; Lee HL; Peng CM; Yang TW; Chen HY; Sung WW; Lin CC
World J Gastroenterol; 2017 Nov; 23(44):7881-7887. PubMed ID: 29209129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
